Literature DB >> 1689832

Torsade de pointes and T-U wave alternans associated with arsenic poisoning.

R E Little1, G N Kay, J B Cavender, A E Epstein, V J Plumb.   

Abstract

Arsenic intoxication is a common form of heavy metal poisoning. Although arsenic-induced circulatory collapse, seizures, and syncope are well known, the potential for serious ventricular arrhythmias is less well recognized. Reported in this study are two cases of arsenic poisoning causing torsade de pointes. Furthermore, marked prolongation of the QT-U interval and the rarely observed phenomenon of T-U wave alternans are demonstrated. Thus, arsenic intoxication may be complicated by prolongation of the QT-U interval and torsade de pointes. T-U wave alternans occurs in the presence of a long QT-U interval and may be an electrocardiographic warning sign of torsade de pointes.

Entities:  

Mesh:

Year:  1990        PMID: 1689832     DOI: 10.1111/j.1540-8159.1990.tb05066.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  10 in total

1.  Two cases of acute promyelocytic leukemia complicated by torsade de pointes during arsenic trioxide therapy.

Authors:  Kensuke Naito; Miki Kobayashi; Naohi Sahara; Kazuyuki Shigeno; Satoki Nakamura; Kaori Shinjo; Tadasu Tobita; Akihiro Takeshita; Ryuzo Ohno; Kazunori Ohnishi
Journal:  Int J Hematol       Date:  2006-05       Impact factor: 2.490

2.  Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance.

Authors:  Luigi X Cubeddu
Journal:  Curr Cardiol Rev       Date:  2009-08

3.  Association between low-level environmental arsenic exposure and QT interval duration in a general population study.

Authors:  Irina Mordukhovich; Robert O Wright; Chitra Amarasiriwardena; Emmanuel Baja; Andrea Baccarelli; Helen Suh; David Sparrow; Pantel Vokonas; Joel Schwartz
Journal:  Am J Epidemiol       Date:  2009-08-21       Impact factor: 4.897

4.  Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo.

Authors:  X-Y Zhao; G-Y Li; Y Liu; L-M Chai; J-X Chen; Y Zhang; Z-M Du; Y-J Lu; B-F Yang
Journal:  Br J Pharmacol       Date:  2008-03-10       Impact factor: 8.739

Review 5.  Drug-induced cardiac arrhythmias: incidence, prevention and management.

Authors:  J C Doig
Journal:  Drug Saf       Date:  1997-10       Impact factor: 5.228

6.  Cardiovascular disease and arsenic exposure in Inner Mongolia, China: a case control study.

Authors:  Timothy J Wade; Yajuan Xia; Judy Mumford; Kegong Wu; X Chris Le; Elizabeth Sams; William E Sanders
Journal:  Environ Health       Date:  2015-04-12       Impact factor: 5.984

Review 7.  Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias.

Authors:  Luigi X Cubeddu
Journal:  Curr Cardiol Rev       Date:  2016

8.  Calcium homeostasis and endoplasmic reticulum stress are involved in Salvianolic acid B-offered protection against cardiac toxicity of arsenic trioxide.

Authors:  Jing-Yi Zhang; Bin Zhang; Min Wang; Wei Wang; Ping Liao; Gui-Bo Sun; Xiao-Bo Sun
Journal:  Oncotarget       Date:  2017-10-26

9.  Arsenic trioxide for acute promyelocytic leukemia in a patient on chronic hemodialysis.

Authors:  Jose Tinajero; Khaled El-Shami; Xiaojun Wu; B Douglas Smith; Matthew J Newman
Journal:  Leuk Res Rep       Date:  2022-03-25

10.  Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study.

Authors:  Judy L Mumford; Kegong Wu; Yajuan Xia; Richard Kwok; Zhihui Yang; James Foster; William E Sanders
Journal:  Environ Health Perspect       Date:  2007-02-14       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.